Free Trial

SOPHiA GENETICS (SOPH) Earnings Date, Estimates & Call Transcripts

SOPHiA GENETICS logo
$6.97 +0.06 (+0.87%)
Closing price 04:00 PM Eastern
Extended Trading
$6.98 +0.01 (+0.14%)
As of 04:56 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Massive. Learn more.

SOPHiA GENETICS Earnings Summary

SOPHiA GENETICS posted Q3 2026 earnings on November 3, 2026, reporting an EPS of -$0.24, which missed analysts' consensus estimates of -$0.20 by $0.04. Quarterly revenue was reported to be $24.27 million, above analyst estimates of $24.03 million. With a trailing EPS of -$1.15, SOPHiA GENETICS's earnings are expected to grow next year, from ($0.77) to ($0.31) per share.

Latest Q3
Earnings Date
Nov. 3Estimated
Consensus EPS
(Nov. 3)
-$0.20
Actual EPS
(Nov. 3)
-$0.24 Missed By -$0.04
Actual Revenue
(Nov. 3)
$24.27M

Q3 2026 Earnings Resources

Get SOPHiA GENETICS Earnings Alerts

Want to stay updated on the latest earnings announcements and upcoming reports? Sign up for Earnings360's daily newsletter to receive timely earnings updates on SOPHiA GENETICS and other key companies, straight to your inbox.

Sign Up
SMS is currently available in Australia, Belgium, Canada, France, Germany, Ireland, Italy, New Zealand, the Netherlands, Singapore, South Africa, Spain, Switzerland, the United Kingdom, and the United States. By entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy.
Skip Charts & View Estimated and Actual Earnings Data

SOPH Earnings Estimates and Actuals by Quarter

The chart below shows up to four years of a company's earnings history. The dark blue line represents the company's actual earnings per share. The light blue area represents the range of Wall Street analysts' earnings estimates for each quarter.

SOPH Estimated and Actual Revenue by Quarter

The chart below shows up to four years of a company's revenue history. The dark blue line represents the company's actual revenue. The light blue line represents the company's estimated revenue based on the consensus of Wall Street analysts for each quarter.

SOPHiA GENETICS Analyst EPS Estimates & Company Guidance

Low, high and average are individual analyst estimates we track. Guidance columns are the company's own outlook, and the revenue estimate was recorded when that guidance was issued.

QuarterNumber of EstimatesLow EstimateHigh EstimateAverage EstimateCompany Revenue GuidanceRevenue Estimate at Guidance
Q2 20261-$0.15-$0.15-$0.15
Q3 20261-$0.13-$0.13-$0.13
Q4 20261-$0.06-$0.06-$0.06
20263-$0.34-$0.34-$0.34
Q1 20271-$0.09-$0.09-$0.09
Q2 20271-$0.08-$0.08-$0.08
Q3 20271-$0.07-$0.07-$0.07
Q4 20271-$0.06-$0.06-$0.06
FY 20274-$0.30-$0.30-$0.30

SOPHiA GENETICS Earnings History by Quarter

Report Date
0 Results
DateQuarterConsensus EstimateReported EPSBeat/MissGAAP EPSRevenue EstimateActual RevenueDetails
11/3/2026Q3 2026-$0.1980-$0.24 -$0.0420-$0.24$24.03M$24.27M
8/5/2026Q2 2026-$0.21-$0.26 -$0.05-$0.30$21.72M$23.31M
5/5/2026Q1 2026-$0.2325-$0.27 -$0.0375-$0.27$20.40M$21.69M
3/3/2026Q4 2025-$0.20-$0.28 -$0.08-$0.28$21.20M$21.71M
11/4/2025Q3 2025-$0.20-$0.30 -$0.10-$0.30$18.13M$19.46M
8/5/2025Q2 2025-$0.25$0.33+$0.58$0.33$17.49M$18.32M
5/6/2025Q1 2025-$0.21-$0.26 -$0.05-$0.26$16.76M$17.78M
3/4/2025Q4 2024-$0.23-$0.23--$0.23$17.71M$17.73M
11/5/2024Q3 2024-$0.24-$0.28 -$0.04-$0.28$15.90M$15.85M

SOPHiA GENETICS Earnings - Frequently Asked Questions

SOPHiA GENETICS (NASDAQ:SOPH) last announced its quarterly earning data on Tuesday, November 3, 2026. Learn more on SOPH's earnings history.

In the previous quarter, SOPHiA GENETICS (NASDAQ:SOPH) missed the analysts' consensus estimate of ($0.20) by $0.04 with a reported earnings per share (EPS) of ($0.24). Learn more on analysts' earnings estimate vs. SOPH's actual earnings.

The conference call for SOPHiA GENETICS's latest earnings report can be listened to online.
Listen to Conference Call

The conference call transcript for SOPHiA GENETICS's latest earnings report can be read online.
Read Transcript

SOPHiA GENETICS (NASDAQ:SOPH) has a recorded annual revenue of $77.27 million.

SOPHiA GENETICS (NASDAQ:SOPH) has a recorded net income of -$79 million. SOPH has generated -$1.15 earnings per share over the last four quarters.

SOPHiA GENETICS's earnings are expected to grow from ($0.77) per share to ($0.31) per share in the next year.


Earnings data for NASDAQ:SOPH is sourced from Fiscal.ai, with the most recent quarter reported on 11/3/2026. New results are added as companies report their earnings.
From Our Partners